Hey Daics personally I’m not factoring Estelle in until 2022 if MYX has anything to do with it. The big question is really as to when MYX gets approval with Nuvaring. They have so far taken 2 years or so since the original announcement and said they expected it to be released in 2019. If they get the approval late Feb then MYX should get the kick it needs. If they haven’t answered the FDA’s questions adequately and don’t get approval and another company does then they’ll miss the early big profits and it’s more disappointment for share holders, more missed opportunities. It’s like sitting around watching grass grow in winter ATM. Hopefully Spring is just around the corner but it’s been a long, long cold Winter thus far. Murphy’s law says sooner or later MYX will get something right whether by good management or by complete accident, either way I don’t think any share holders will really care....
MYX Price at posting:
48.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)